Latest Views & News

OptiBiotix Health – current trading disappointment, but highly favourable risk/reward here?

By Tom Winnifrith & Steve Moore | Friday 26 August 2022

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

OptiBiotix Health (OPTI) has announced that it now expects half-year sales in its new structure to be materially lower than expected and, though it expects sales normalising in the second half and healthy growth next year, the current year is to now be “insufficient to make up the H1 deficit”. We profusely apologise for the short-term disappointment though, having spoken to the company, what to do now with the shares down at 20p to buy, a £17.6 million market cap?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



The ShareProphets Sunday Pub Quiz #160



Gyrations at Victoria Carpets



GOTCHA: admits it is fucked



Stuff happens but we are not stuffed



The ShareProphets Sunday Pub Quiz #159



Challenges continue at Ocado



Iconic Labs – back from the dead?



Pure Gold – Pure Ramping!

Sunday »


The ShareProphets Sunday Pub Quiz #158



Buy Orcadian Energy